Astellas Pharma Inc. (TYO:4503)
2,283.00
+159.00 (7.49%)
May 29, 2026, 3:30 PM JST
Astellas Pharma Stock Forecast
Stock Price Forecast
The 4 analysts that cover Astellas Pharma stock have a consensus rating of "Hold" and an average price target of ¥2,450, which forecasts a 7.31% increase in the stock price over the next year. The lowest target is ¥2,200 and the highest is ¥2,800.
Price Target: ¥2,450 (+7.31%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Astellas Pharma stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 7 | 9 | 10 | 9 | 9 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Hold Maintains ¥2,600 → ¥2,400 | Hold | Maintains | ¥2,600 → ¥2,400 | +5.12% | May 25, 2026 |
| Bernstein | Bernstein | Hold Maintains ¥2,200 | Hold | Maintains | ¥2,200 | -3.64% | May 12, 2026 |
| Citi | Citi | Hold Maintains ¥2,500 → ¥2,400 | Hold | Maintains | ¥2,500 → ¥2,400 | +5.12% | May 1, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Maintains ¥2,800 → ¥2,950 | Buy | Maintains | ¥2,800 → ¥2,950 | +29.22% | Apr 28, 2026 |
| Jefferies | Jefferies | Buy Maintains ¥2,800 | Buy | Maintains | ¥2,800 | +22.65% | Mar 24, 2026 |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.